Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Global Health Challenges: Neurology in Developing Countries

Monday 04/11/11
06:30 AM - 08:30 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³»­
Global Health and Neuroepidemiology
Participants should be familiar with the global health challenges and differential diagnosis and treatment of common neurologic illnesses in developing countries.
No CME available
Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Systems-based Practice
Trainee, General Neurologist, Specialist Neurologist, Non-neurologist
Didactic, Audience Participation
Event Timeline
06:30 AM - 07:10 AM Pharmacoeconomics and Vaccinations
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³»­
06:30 AM - 08:30 AM Break
07:10 AM - 07:50 AM Nervous System Infections in Developing Countries
Allen J. Aksamit, Jr., MD, FÂ鶹´«Ã½Ó³»­
07:50 AM - 08:30 AM The World Health Organization in Developing Countries
Farrah J. Mateen, MD, PhD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Allen J. Aksamit, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Aksamit has nothing to disclose.
Gregory D. Cascino, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Farrah J. Mateen, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.